Bailong Chuangyuan's performance of H1 2021 expected to rise

On 19 July, Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (Bailong Chuangyuan) released its strong performance forecast of H1 2021:Total revenue: USD47.40 million (RMB306.47 million), up by 27.75% YoY;Net profit attributable to shareholders: USD7.86...

Sweeteners China News 202108

www.cnchemicals.com